蛋白质治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00002856
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

蛋白质治疗市场预计在 2024 年至 2031 年期间的复合年增长率为 6.5%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

蛋白质治疗市场报告涵盖一系列治疗性蛋白质,包括单克隆抗体和重组蛋白。它深入探讨了肿瘤学、免疫学和罕见疾病等关键治疗领域。该报告重点介绍了市场趋势、规模和增长潜力,并对监管格局和竞争环境进行了深入分析。利益相关者将在这个充满活力且不断扩张的行业中发现投资和发展的机会。

报告目的

The Insight Partners 的《蛋白质治疗市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

蛋白质治疗市场细分

 

产品

  • 单克隆抗体
  • 胰岛素
  • 融合蛋白
  • 促红细胞生成素
  • 干扰素
  • 人类生长激素
  • 促卵泡激素

应用

  • 代谢紊乱
  • 免疫疾病
  • 血液系统疾病
  • 癌症
  • 荷尔蒙失调
  • 遗传性疾病

最终用户

  • 制药公司
  • 医疗服务提供商
  • 研究组织及学术研究机构

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

蛋白质治疗市场:战略洞察

Protein Therapeutics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

蛋白质治疗市场的增长动力

  • 慢性病发病率上升:由于对先进治疗方案的极度需求,癌症、糖尿病和自身免疫性疾病等慢性病的发病已成为推动蛋白质治疗市场发展的主要因素。
  • 关注靶向治疗:由于制药公司高度参与生物制药研究,并且预计未来该领域将有大量资金投入,因此对靶向治疗的关注度增加是另一个主要的市场驱动力,从而推动了市场增长。
  • 具有适当安全性的蛋白质疗法:最近,由于蛋白质工程和重组 DNA 技术的不断进步,蛋白质疗法已经以更高的质量和数量在市场上推出,并具有卓越的安全性。

蛋白质治疗市场未来趋势

  • 生物仿制药的快速普及:蛋白质治疗市场的主要趋势包括生物仿制药的快速普及,生物仿制药为生物制剂提供了具有成本竞争力的替代品,从而增加了患者获得急需治疗的机会。
  • 人工智能和机器学习的使用:在药物设计领域使用人工智能和机器学习来加速新的蛋白质分子实体,现在专注于联合疗法。
  • 单克隆抗体 (mAb) 的增长:单克隆抗体 (mAb) 仍然是市场上领先的蛋白质治疗药物,尤其是在治疗癌症、自身免疫性疾病和传染病方面。mAb 的开发具有更高的功效、特异性和更少的副作用。临床开发中基于 mAb 的疗法数量不断增加,以及它们在市场上的成功促进了该领域的持续增长。

蛋白质治疗市场机会

  • 在罕见病治疗中的应用:罕见病和孤儿病适应症领域的新型治疗蛋白的增殖。
  • 投资生物技术:大量生物技术投资的扩大以及产学研合作将为突破性发现铺平道路。
  • 医疗支出的增长:全球医疗支出不断上升以及特别是新兴市场对新型治疗方法的未满足需求表明该领域存在着巨大的机遇。

 

蛋白质治疗市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响蛋白质治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的蛋白质治疗市场细分和地理位置。

Protein Therapeutics Market
  • 获取蛋白质治疗市场的区域特定数据

蛋白质治疗市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)6.5%
史料2021-2023
预测期2025-2031
涵盖的领域按产品
  • 单克隆抗体
  • 胰岛素
  • 融合蛋白
  • 促红细胞生成素
  • 干扰素
  • 人类生长激素
  • 促卵泡激素
按应用
  • 代谢紊乱
  • 免疫疾病
  • 血液系统疾病
  • 癌症
  • 荷尔蒙失调
  • 遗传性疾病
按最终用户
  • 制药公司
  • 医疗服务提供商
  • 研究组织及学术研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 诺和诺德公司
  • 詹森全球服务有限公司 (强生服务公司)
  • 安进公司
  • 阿斯利康
  • 巴克斯特
  • 勃林格殷格翰国际有限公司
  • 梯瓦制药工业有限公司
  • 协和发酵麒麟株式会社
  • 辉瑞公司

 

蛋白质治疗市场参与者密度:了解其对业务动态的影响

蛋白质治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在蛋白质治疗市场运营的主要公司有:

  1. 诺和诺德公司
  2. 詹森全球服务有限公司 (强生服务公司)
  3. 安进公司
  4. 阿斯利康
  5. 巴克斯特

免责声明上面列出的公司没有按照任何特定顺序排列。


Protein Therapeutics Market

 

  • 获取蛋白质治疗市场顶级关键参与者概览

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖蛋白质治疗市场的产品、服务、类型和最终用户的分析,提供整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,蛋白质治疗市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
protein-therapeutics-market-report-deliverables-img1
protein-therapeutics-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What are the deliverable formats of the Protein Therapeutics Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are key players in Protein Therapeutics Market?

Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc

What is expected CAGR in the Protein Therapeutics Market?

The market is expected to register a CAGR of 6.5% during 2023-2031

What are factors impacting on the Protein Therapeutics market?

Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.

What are future trends in the Protein Therapeutics market?

The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd
protein-therapeutics-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.